Literature DB >> 12359482

Bluetongue virus in the Mediterranean Basin 1998-2001.

P S Mellor1, E J Wittmann.   

Abstract

Bluetongue (BT) exists around the world in a broad band covering much of the Americas, Africa, southern Asia, northern Australia and, occasionally, the southern fringe of Europe. It is considered to be one of the most important diseases of domestic livestock. Recently the virus causing this disease has extended its range northwards into areas of Europe never before affected and has persisted in many of these locations causing the greatest epizootic of the disease on record. The reasons for this dramatic change in BT epidemiology are complex but are linked to recent extensions in the distribution of its major vector, Culicoidesimicola, to the involvement of novel Culicoides vector(s) and to an apparent ability of the virus to overwinter in the absence of adult vectors. In addition, the effects of these changes have been exacerbated by problems in control, particularly in relation to vaccination. This paper explores these areas and highlights prospects for the future.

Entities:  

Mesh:

Year:  2002        PMID: 12359482     DOI: 10.1053/tvjl.2002.0713

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  55 in total

1.  The genome sequence of a reassortant bluetongue virus serotype 3 from India.

Authors:  Narender S Maan; Sushila Maan; Marc Guimera; Kyriaki Nomikou; Elizabeth Morecroft; Gillian Pullinger; Manjunatha N Belaganahalli; Peter P C Mertens
Journal:  J Virol       Date:  2012-06       Impact factor: 5.103

2.  Impact of mechanical disturbance on the emergence of Culicoides from cowpats.

Authors:  Renke Lühken; Ellen Kiel; Sonja Steinke
Journal:  Parasitol Res       Date:  2014-01-23       Impact factor: 2.289

3.  The evolutionary dynamics of bluetongue virus.

Authors:  Giovanna Carpi; Edward C Holmes; Andrew Kitchen
Journal:  J Mol Evol       Date:  2010-06-05       Impact factor: 2.395

4.  Monitoring bluetongue virus vectors in Andalusia (SW Europe): Culicoides species composition and factors affecting capture rates of the biting midge Culicoides imicola.

Authors:  Jesús M Pérez; Juan A García-Ballester; Jorge R López-Olvera; Emmanuel Serrano
Journal:  Parasitol Res       Date:  2012-05-19       Impact factor: 2.289

5.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

6.  Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor.

Authors:  Eva Calvo-Pinilla; Teresa Rodríguez-Calvo; Juan Anguita; Noemí Sevilla; Javier Ortego
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

7.  Evolution and phylogenetic analysis of full-length VP3 genes of Eastern Mediterranean bluetongue virus isolates.

Authors:  Kyriaki Nomikou; Chrysostomos I Dovas; Sushila Maan; Simon J Anthony; Alan R Samuel; Maria Papanastassopoulou; Narender S Maan; Olga Mangana; Peter P C Mertens
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

8.  Assay development and high-throughput antiviral drug screening against Bluetongue virus.

Authors:  Qianjun Li; Clinton Maddox; Lynn Rasmussen; Judith V Hobrath; Lucile E White
Journal:  Antiviral Res       Date:  2009-06-24       Impact factor: 5.970

9.  Spatial and temporal evolution of bluetongue virus in wild ruminants, Spain.

Authors:  Francisco Ruiz-Fons; Alvaro R Reyes-García; Vicente Alcaide; Christian Gortázar
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

10.  Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland.

Authors:  Martin A Hofmann; Sandra Renzullo; Markus Mader; Valérie Chaignat; Gabriella Worwa; Barbara Thuer
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.